The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland
BMJPublished 27 July 2002Open access
S Crawford, Jonathan A Davis, Nadeem A Siddiqui, Linda de Caestecker, Charles R Gillis, David Hole
Citations121
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Delay in the delivery of treatment for gynaecological cancers has been previously investigated. 1 2 In some cases, the delay reflects the illness behaviour of women; in others, it was inherent in the system for delivering health care. Few studies have linked delay in treatment with survival, although a study from Israel found that survival from endometrial cancer was not affected by a delay in treatment of four months. 3 We investigated links between delays in treatment and survival, using a recently completed audit of endometrial cancer treatment in Scotland.
Keywords
Medicine
The LancetSurgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
1,766 Citations2000Carien L. Creutzberg, W L van Putten +10 more
Postoperative radiotherapy in stage-1 endometrial carcinoma reduces locoregional recurrence but has no impact on overall survival, while radiotherapy increases treatment-related morbidity and survival after relapse.
American Journal of Obstetrics and GynecologyThe effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma
38 Citations1995Joseph Menczer, Haim Krissi +5 more
It is concluded that delay of diagnosis (< 1 year) and of treatment of < 4 months do not compromise survival of patients with endometrial cancer.
